References

European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

10.1093/ejendo/lvad066 · 2023 · External reference

Cohort study of patients with adrenal lesions discovered incidentally

10.1002/bjs.7566 · 2011 · External reference

Differences between bilateral adrenal incidentalomas and unilateral lesions

10.1001/jamasurg.2015.1683 · 2015 · External reference

Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study

10.7326/m22-1619 · 2022 · External reference

Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study

10.1016/s2213-8587(20)30314-4 · 2020 · External reference

Predicting morphological and functional variations of benign adrenal incidentalomas in relation to initial characteristics

10.3389/fendo.2023.1179817 · 2023 · External reference

Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis

10.7326/m18-3630 · 2019 · External reference

The functional status of incidentally discovered bilateral adrenal lesions

10.1111/j.1365-2265.2011.04013.x · 2011 · External reference

Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications

10.1530/eje-13-0848 · 2014 · External reference

High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management

10.1111/j.1365-2265.2010.03963.x · 2011 · External reference

Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study

10.7326/m21-1737 · 2022 · External reference

The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known Malignancy

10.2214/ajr.07.2799 · 2008 · External reference

Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia

10.1210/endrev/bnac034 · 2023 · External reference

Differences in growth rate on CT of adrenal adenomas and Malignant adrenal nodules

10.2214/ajr.19.21342 · 2019 · External reference

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

10.1530/eje-10-0058 · 2010 · External reference

Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study

10.1016/s2213-8587(21)00236-9 · 2021 · External reference

High prevalence of smoking in patients with adrenal incidentalomas: causality or case selection

10.1530/eje-20-0033 · 2020 · External reference

Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL

10.1007/s12020-022-03228-z · 2023 · External reference

Attenuation value in adrenal incidentalomas: a longitudinal study

10.3389/fendo.2021.794197 · 2021 · External reference

Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up

10.1111/cen.13294 · 2017 · External reference

Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study

10.1007/s12020-020-02476-1 · 2021 · External reference

Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas

10.1007/s42000-022-00406-6 · 2023 · External reference

Prevalence and natural history of adrenal incidentalomas

10.1530/eje.0.1490273 · 2003 · External reference

Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice

10.1530/eje-17-0372 · 2017 · External reference

Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study

10.1530/eje-08-0299 · 2009 · External reference

Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

10.1038/sj.bjc.6602459 · 2005 · External reference

Long-term follow-up study of patients with adrenal incidentalomas

10.1530/eje.0.1470489 · 2002 · External reference

Clinical characteristics and follow-up results of adrenal incidentaloma

10.1055/a-1079-4915 · 2021 · External reference

Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas

10.3390/jcm10235509 · 2021 · External reference

Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas

10.1007/s40618-021-01539-y · 2021 · External reference

Natural history of nonfunctioning adrenal incidentalomas: a 10-year longitudinal follow-up study

10.1530/ec-21-0196 · 2021 · External reference

Beyond symptomatology: a comparative analysis of unilateral and bilateral macronodular mild autonomous cortisol secretion

10.1111/cen.15109 · 2024 · External reference

Diagnosis and management of primary bilateral macronodular adrenal hyperplasia

10.1530/erc-19-0240 · 2019 · External reference

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study

10.1016/s2213-8587(26)00098-7 · 2026 · External reference

Cardiometabolic risk in bilateral versus unilateral nonfunctioning adrenal incidentalomas: evidence from a large referral center cohort

10.1016/j.eprac.2026.03.005 · 2026 · External reference